Mechanical hyperalgesia correlates with insulin deficiency in normoglycemic streptozotocin-treated rats

Neurobiology of Disease

Volumn 24, Issue 2, 2006, Pages 384-394

  Romanovsky, Dmitry ^a   Cruz, Nancy F ^a   Dienel, Gerald A ^a   Dobretsov, Maxim ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Diabetic neuropathy; Hyperglycemia; Insulin; Mechanical hyperalgesia; Pain; Streptozotocin; Type I diabetes

Indexed keywords

GLUCOSE; RECOMBINANT HUMAN INSULIN; SORBITOL; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC NEUROPATHY; DISEASE COURSE; GLUCOSE BLOOD LEVEL; HYPERALGESIA; HYPERGLYCEMIA; HYPOINSULINEMIA; HYPOTHESIS; INSULIN BLOOD LEVEL; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NEUROPATHY; NOCICEPTION; NONHUMAN; PAIN; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; SCIATIC NERVE; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; DISEASE MODELS, ANIMAL; GLUCOSE; HYPERALGESIA; INSULIN; MALE; MECHANORECEPTORS; NOCICEPTORS; PAIN THRESHOLD; PERIPHERAL NERVES; PHYSICAL STIMULATION; RATS; RATS, SPRAGUE-DAWLEY; SCIATIC NERVE; SORBITOL;

EID: 33750010094     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2006.07.009     Document Type: Article

References (52)

1. Animal Models of Diabetes. In: Sima A.A., and Shafrir E. (Eds) (2001), Harwood Academic Publishers, Amsterdam 1-364
2. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 29 (2006) S4-S42
3. Apfel S.C., Arezzo J.C., Brownlee M., Fedoroff H., and Kessler J.A. Nerve growth factor administration protects against experimental sensory neuropathy. Brain Res. 634 (1994) 7-12
4. Biessels G.J., Cristino N.A., Rutten G.J., Hamers F.P., Erkelens D.W., and Gispen W.H. Neurophysiological changes in the central and peripheral nervous system of streptozotocin-diabetic rats. Course of development and effects of insulin treatment. Brain 122 Pt. 4 (1999) 757-768
5. Bonica J.J. In: Loeser J.D., Chapman C.R., and W.E. (Eds). The Management of Pain (1990), Lea and Febiger, Philadelphia, London 1-958
6. Boulton A.J., Malik R.A., Arezzo J.C., and Sosenko J.M. Diabetic somatic neuropathies. Diabetes Care 27 (2004) 1458-1483
7. Brussee V., Cunningham F.A., and Zochodne D.W. Direct insulin signaling of neurons reverses diabetic neuropathy. Diabetes 53 (2004) 1824-1830
8. Burcelin R., Eddouks M., Kande J., Assan R., and Girard J. Evidence that GLUT-2 mRNA and protein concentrations are decreased by hyperinsulinaemia and increased by hyperglycaemia in liver of diabetic rats. Biochem. J. 288 Pt. 2 (1992) 675-679
9. Calcutt N.A., Jorge M.C., Yaksh T.L., and Chaplan S.R. Tactile allodynia and formalin hyperalgesia in streptozotocin-diabetic rats: effects of insulin, aldose reductase inhibition and lidocaine. Pain 68 (1996) 293-299
10. Calcutt N.A., Malmberg A.B., Yamamoto T., and Yaksh T.L. Tolrestat treatment prevents modification of the formalin test model of prolonged pain in hyperglycemic rats. Pain 58 (1994) 413-420
11. Calcutt N.A., Freshwater J.D., and Mizisin A.P. Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor. Diabetologia 47 (2004) 718-724
12. Chan A.W., MacFarlane I.A., and Bowsher D. Short term fluctuations in blood glucose concentrations do not alter pain perception in diabetic-patients with and without painful peripheral neuropathy. Diabetes Res. 14 (1990) 15-19
13. Courteix C., Bardin M., Massol J., Fialip J., lavarenne J., and Eschalier A. Daily insulin treatment relieves long-term hyperalgesia in streptozocin diabetic rats. NeuroReport 7 (1996) 1922-1924
14. Dachicourt N., Serradas P., Bailbe D., Kergoat M., Doare L., and Portha B. Glucagon-like peptide-1(7-36)-amide confers glucose sensitivity to previously glucose-incompetent beta-cells in diabetic rats: in vivo and in vitro studies. J. Endocrinol. 155 (1997) 369-376
15. DCCT. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N. Engl. J. Med. 329 (1993) 977-986
16. Dienel G.A., Cruz N.F., Mori K., and Sokoloff L. Acid lability of metabolites of 2-deoxyglucose in rat brain: implications for estimates of kinetic parameters of deoxyglucose phosphorylation and transport between blood and brain. J. Neurochem. 54 (1990) 1440-1448
17. Dobretsov M., Hastings S.L., Stimers J.R., and Zhang J.-M. Mechanical hyperalgesia in rats with chronic perfusion of lumbar dorsal root ganglion with hyperglycemic solution. J. Neurosci. Methods 110 (2001) 9-15
18. Dobretsov M., Hastings S.L., Romanovsky D., Stimers J.R., and Zhang J.-M. Mechanical hyperalgesia in rat models of systemic and local hyperglycemia. Brain Res. 960 (2003) 174-183
19. Eisenbarth G.S. Type I diabetes mellitus. A chronic autoimmune disease. N. Engl. J. Med. 314 (1986) 1360-1368
20. Fox A., Eastwood C., Gentry C., Manning D., and Urban L. Critical evaluation of the streptozotocin model of painful diabetic neuropathy in the rat. Pain 81 (1999) 307-316
21. Frasca F., Pandini G., Scalia P., Sciacca L., Mineo R., Costantino A., Goldfine I.D., Belfiore A., and Vigneri R. Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol. Cell. Biol. 19 (1999) 3278-3288
22. Gelling R.W., Overduin J., Morrison C.D., Morton G.J., Frayo R.S., Cummings D.E., and Schwartz M.W. Effect of uncontrolled diabetes on plasma ghrelin concentrations and ghrelin-induced feeding. Endocrinology 145 (2004) 4575-4582
23. Gerbi A., Maixent J.-M., Jamme I., Pierlovisi M., Coste T., Pieroni G., Nouvelot A., Vague P., and Raccah D. Alterations of Na,K-ATPase isoenzymes in rat diabetic neuropathy: protective effect of dietary supplementation with n-3 fatty acids. J. Neurochem. 71 (1998) 732-740
24. Gracely R.H., Eliav E., and Hansson P. In: Dostrovsky J.O., Carr D.L., and Koltzenburg M. (Eds). Quantitative Sensory Testing: Clinical Considerations and New Methods (2004), IASP Press, Seattle 589-600
25. Grey N.J., Goldring S., and Kipnis D.M. The effect of fasting, diet, and actinomycin D on insulin secretion in the rat. J. Clin. Invest 49 (1970) 881-889
26. Huang T.J., Price S.A., Chilton L., Calcutt N.A., Tomlinson D.R., Verkhratsky A., and Fernyhough P. Insulin prevents depolarization of the mitochondrial inner membrane in sensory neurons of type 1 diabetic rats in the presence of sustained hyperglycemia. Diabetes 52 (2003) 2129-2136
27. Ishii D.N. Implication of insulin-like growth factors in the pathogenesis of diabetic neuropathy. Brain Res. Brain Res. Rev. 20 (1995) 47-67
28. Khan G.M., Chen S.R., and Pan H.L. Role of primary afferent nerves in allodynia caused by diabetic neuropathy in rats. Neuroscience 114 (2002) 291-299
29. Kobayashi T., and Kamata K. Effect of insulin treatment on smooth muscle contractility and endothelium-dependent relaxation in rat aortae from established STZ-induced diabetes. Br. J. Pharmacol. 127 (1999) 835-842
30. Li F., Obrosova I.G., Abatan O., Tian D., Larkin D., Stuenkel E.L., and Stevens M.J. Taurine replacement attenuates hyperalgesia and abnormal calcium signaling in sensory neurons of STZ-D rats. Am. J. Physiol. Endocrinol. Metab. 288 (2005) E29-E36
31. Maneuf Y.P., Blake R., Andrews N.A., and McKnight A.T. Reduction by gabapentin of K+-evoked release of [3H]-glutamate from the caudal trigeminal nucleus of the streptozotocin-treated rat. Br. J. Pharmacol. 141 (2004) 574-579
32. Marquardt D.W. An algorithm for least-squares estimation of nonlinear parameters. J. Soc. Ind. Appl. Math. 11 (1963) 431-441
33. Navarro X., Kennedy W.R., and Fries T.J. Small nerve fiber dysfunction in diabetic neuropathy. Muscle Nerve 12 (1989) 498-507
34. Olefsky J.M. Insensitivity of large rat adipocytes to the antilipolytic effects of insulin. J. Lipid Res. 18 (1977) 459-464
35. Piercy V., Banner S.E., Bhattacharyya A., Parsons A.A., Sanger G.J., Smith S.A., and Bingham S. Thermal, but not mechanical, nociceptive behavior is altered in the Zucker Diabetic Fatty rat and is independent of glycemic status. J. Diabetes Its Complicat. 13 (1999) 163-169
36. Qiang X., Satoh J., Sagara M., Fukuzawa M., Masuda T., Sakata Y., Muto G., Muto Y., Takahashi K., and Toyota T. Inhibitory effect of troglitazone on diabetic neuropathy in streptozotocin-induced diabetic rats. Diabetologia 41 (1998) 1321-1326
37. Romanovsky D., Hastings S.L., Stimers J.R., and Dobretsov M. Relevance of hyperglycemia to early mechanical hyperalgesia in streptozotocin-induced diabetes. J. Peripher. Nerv. Syst. 9 (2004) 62-69
38. Rossetti L., and Giaccari A. Relative contribution of glycogen synthesis and glycolysis to insulin-mediated glucose uptake. A dose-response euglycemic clamp study in normal and diabetic rats. J. Clin. Invest. 85 (1990) 1785-1792
39. Rossetti L., Shulman G.I., Zawalich W., and DeFronzo R.A. Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats. J. Clin. Invest. 80 (1987) 1037-1044
40. Schmidt R.E., Dorsey D.A., Beaudet L.N., Parvin C.A., Zhang W., and Sima A.A.F. Experimental rat models of types 1 and 2 diabetes differ in sympathetic neuroaxonal dystrophy. J. Neuropathol. Exp. Neurol. 63 (2004) 450-460
41. Sechi L.A., Griffin C.A., and Schambelan M. Effect of dietary sodium chloride on insulin receptor number and mRNA levels in rat kidney. Am. J. Physiol. 266 (1994) F31-F38
42. Sherman W.R., and Stewart M.A. Identification of sorbitol in mammalian nerve. Biochem. Biophys. Res. Commun. 22 (1966) 492-497
43. Singleton J.R., Smith A.G., and Bromberg M.B. Painful sensory polyneuropathy associated with impaired glucose tolerance. Muscle Nerve 24 (2001) 1225-1228
44. Sugimoto K., Murakawa Y., and Sima A.A.F. Diabetic neuropathy-A continuing enigma. Diabetes/Metab. Res. Rev. 16 (2000) 408-433
45. Sugimoto K., Murakawa Y., Zhang W., Xu G., and Sima A.A.F. Insulin receptor in rat peripheral nerve: its localization and alternatively spliced isoforms. Diabetes/Metab. Res. Rev. 16 (2000) 354-363
46. Sugimoto K., Murakawa Y., and Sima A.A.F. Expression and localization of insulin receptor in rat dorsal root ganglion and spinal cord. J. Peripher. Nerv. Syst. 7 (2002) 44-53
47. Suzuki Y., Sato J., Kawanishi M., and Mizumura K. Tissue glucose level modulates the mechanical responses of cutaneous nociceptors in streptozotocin-diabetic rats but not normal rats in vitro. Pain 99 (2002) 475-484
48. Thye-Ronn P., Sindrup S.H., Arendt-Nielsen L., Brennum J., Hother-Nielsen O., and Beck-Nielsen H. Effect of short-term hyperglycemia per se on nociceptive and non-nociceptive thresholds. Pain 56 (1994) 43-49
49. Tishler M., Smorodin T., Vazina-Amit M., Ramot Y., Koffler M., and Fishel B. Fibromyalgia in diabetes mellitus. Rheumatol. Int. 23 (2003) 171-173
50. Wuarin-Bierman L., Zahnd G.R., Kaufmann F., Burcklen L., and Adler J. Hyperalgesia in spontaneous and experimental animal models of diabetic neuropathy. Diabetologia 30 (1987) 653-658
51. Xu G.G., and Rothenberg P.L. Insulin receptor signaling in the beta-cell influences insulin gene expression and insulin content: evidence for autocrine beta-cell regulation. Diabetes 47 (1998) 1243-1252
52. Zhuang H.-X., Wuarin L., Fei Z.-J., and Ishii D.N. Insulin-like growth factor (IGF) gene expression is reduced in neural tissues and liver from rats with non-insulin-dependent diabetes mellitus, and IGF treatment ameliorates diabetic neuropathy. J. Pharmacol. Exp. Ther. 283 (1997) 366-374